Verrica Pharmaceuticals (VRCA)
(Delayed Data from NSDQ)
$2.08 USD
-0.22 (-9.57%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $2.10 +0.02 (0.96%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, Verrica Pharmaceuticals (VRCA) reported earnings of -$0.31 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive earnings surprise of 27.91%. Look out for VRCA's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year decrease of 12.5%.
Earnings History
Price & Consensus
Zacks News for VRCA
Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates
VRCA: What are Zacks experts saying now?
Zacks Private Portfolio Services